Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Parkinson's Disease

Free Subscription 22.11.2021 1 Brain Res 1 Exp Neurol 2 J Neural Transm (Vienna) 1 J Neurochem 1 J Neurosci 5 Mov Disord 1 Nat Rev Neurol 1 Neurobiol Dis 1 Neurol Genet 1 Neurology 1 Neuron 1 PLoS Genet 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Brain Res

1. ARAUJO-SILVA F, Santinelli FB, Felipe I Imaizumi L, Silveira APB, et al
   Temporal dynamics of cortical activity and postural control in response to the first levodopa dose of the day in people with Parkinson's disease.
   Brain Res. 2021 Nov 14:147727. doi: 10.1016/j.brainres.2021.147727.
   PubMed         Abstract available
   
   

   
   Exp Neurol

2. OH T, Daadi ES, Kim J, Daadi EW, et al
   Dopamine D3 receptor ligand suppresses the expression of levodopa-induced dyskinesia in nonhuman primate model of parkinson's disease.
   Exp Neurol. 2021;347:113920.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

3. LIM JL, Lohmann K, Tan AH, Tay YW, et al
   Glucocerebrosidase (GBA) gene variants in a multi-ethnic Asian cohort with Parkinson's disease: mutational spectrum and clinical features.
   J Neural Transm (Vienna). 2021 Nov 15. pii: 10.1007/s00702-021-02421.
   PubMed         Abstract available
   
   
4. MULLER T, Kuhn W
   Complex motion series performance differs between previously untreated patients with Parkinson's disease and controls.
   J Neural Transm (Vienna). 2021 Nov 12. pii: 10.1007/s00702-021-02416.
   PubMed         Abstract available
   
   

   
   J Neurochem

5. GOLDSTEIN DS, Sullivan P, Holmes C, Lamotte G, et al
   Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies.
   J Neurochem. 2021;158:554-568.
   PubMed         Abstract available
   
   

   
   J Neurosci

6. RYAN BJ, Bengoa-Vergniory N, Williamson M, Kirkiz E, et al
   REST Protects Dopaminergic Neurons from Mitochondrial and alpha-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model.
   J Neurosci. 2021;41:3731-3746.
   PubMed         Abstract available
   
   

   
   Mov Disord

7. LANE EL, Harrison DJ, Ramos-Varas E, Hills R, et al
   Spontaneous Graft-Induced Dyskinesias Are Independent of 5-HT Neurons and Levodopa Priming in a Model of Parkinson's Disease.
   Mov Disord. 2021 Nov 12. doi: 10.1002/mds.28856.
   PubMed         Abstract available
   
   
8. CHEN C, Mossman E, Malko P, McDonald D, et al
   Astrocytic Changes in Mitochondrial Oxidative Phosphorylation Protein Levels in Parkinson's Disease.
   Mov Disord. 2021 Nov 15. doi: 10.1002/mds.28849.
   PubMed         Abstract available
   
   
9. COSENTINO C, Torres L, Velez M, Nunez Y, et al
   SARS-CoV-2 Vaccines and Motor Symptoms in Parkinson's Disease.
   Mov Disord. 2021 Nov 14. doi: 10.1002/mds.28851.
   PubMed        
   
   
10. SURMEIER DJ, Nguyen JT, Lancki N, Venuto CS, et al
    Re-Analysis of the STEADY-PD II Trial-Evidence for Slowing the Progression of Parkinson's Disease.
    Mov Disord. 2021 Nov 12. doi: 10.1002/mds.28850.
    PubMed         Abstract available
    
    
11. VOGEL A, Claus I, Ahring S, Gruber D, et al
    Endoscopic Characteristics of Dysphagia in Multiple System Atrophy Compared to Parkinson's Disease.
    Mov Disord. 2021 Nov 13. doi: 10.1002/mds.28854.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurol

12. WOOD H
    VEGFA mediates blood-brain barrier disruption in Parkinson disease.
    Nat Rev Neurol. 2021 Nov 17. pii: 10.1038/s41582-021-00594.
    PubMed        
    
    

    
    Neurobiol Dis

13. HANG L, Wang Z, Foo ASC, Goh GWY, et al
    Conditional disruption of AMP kinase in dopaminergic neurons promotes Parkinson's disease-associated phenotypes in vivo.
    Neurobiol Dis. 2021;161:105560.
    PubMed         Abstract available
    
    

    
    Neurol Genet

14. FOWLER AJ, Ahn J, Hebron M, Chiu T, et al
    CSF MicroRNAs Reveal Impairment of Angiogenesis and Autophagy in Parkinson Disease.
    Neurol Genet. 2021;7:e633.
    PubMed         Abstract available
    
    

    
    Neurology

15. PRINGSHEIM T, Day GS, Smith DB, Rae-Grant A, et al
    Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee.
    Neurology. 2021;97:942-957.
    PubMed         Abstract available
    
    

    
    Neuron

16. STOJKOVSKA I, Wani WY, Zunke F, Belur NR, et al
    Rescue of alpha-synuclein aggregation in Parkinson's patient neurons by synergistic enhancement of ER proteostasis and protein trafficking.
    Neuron. 2021 Nov 9. pii: S0896-6273(21)00862.
    PubMed         Abstract available
    
    

    
    PLoS Genet

17. GIRARD V, Jollivet F, Knittelfelder O, Celle M, et al
    Abnormal accumulation of lipid droplets in neurons induces the conversion of alpha-Synuclein to proteolytic resistant forms in a Drosophila model of Parkinson's disease.
    PLoS Genet. 2021;17:e1009921.
    PubMed         Abstract available
    
    

    
    PLoS One

18. NEJTEK VA, James RN, Salvatore MF, Alphonso HM, et al
    Premature cognitive decline in specific domains found in young veterans with mTBI coincide with elder normative scores and advanced-age subjects with early-stage Parkinson's disease.
    PLoS One. 2021;16:e0258851.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: